FRI-219 - Full dose, daily sofosbuvir treatment in end-stage renal disease: tolerability & safety of largest ESRD patient cohort exposed to this drug

H.E Nazario, A.A Modi + Show 4 more

https://doi.org/10.1016/s0168-8278(17)31413-7

Copy DOI

Publication Date: Jan 1, 2017

Abstract

FRI-219 - Full dose, daily sofosbuvir treatment in end-stage renal disease: tolerability & safety of largest ESRD patient cohort exposed to this drug

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author